BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26904167)

  • 1. TGF-β and Hypoxia/Reoxygenation Promote Radioresistance of A549 Lung Cancer Cells through Activation of Nrf2 and EGFR.
    Lee SL; Ryu H; Son AR; Seo B; Kim J; Jung SY; Song JY; Hwang SG; Ahn J
    Oxid Med Cell Longev; 2016; 2016():6823471. PubMed ID: 26904167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
    Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
    Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
    Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling.
    Ryu D; Lee JH; Kwak MK
    Arch Pharm Res; 2020 Dec; 43(12):1297-1310. PubMed ID: 33242180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS/Autophagy/Nrf2 Pathway Mediated Low-Dose Radiation Induced Radio-Resistance in Human Lung Adenocarcinoma A549 Cell.
    Chen N; Wu L; Yuan H; Wang J
    Int J Biol Sci; 2015; 11(7):833-44. PubMed ID: 26078725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
    Deng X; Rui W; Zhang F; Ding W
    Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2-AKT interactions regulate heme oxygenase 1 expression in kidney epithelia during hypoxia and hypoxia-reoxygenation.
    Potteti HR; Tamatam CR; Marreddy R; Reddy NM; Noel S; Rabb H; Reddy SP
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F1025-F1034. PubMed ID: 27582105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone.
    Liu W; Mao L; Ji F; Chen F; Wang S; Xie Y
    Oncotarget; 2017 Jan; 8(2):2594-2603. PubMed ID: 27911877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species.
    Kolamunne RT; Dias IH; Vernallis AB; Grant MM; Griffiths HR
    Redox Biol; 2013; 1(1):418-26. PubMed ID: 24191235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.
    Kawano Y; Iwama E; Tsuchihashi K; Shibahara D; Harada T; Tanaka K; Nagano O; Saya H; Nakanishi Y; Okamoto I
    Lung Cancer; 2017 Nov; 113():72-78. PubMed ID: 29110853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage.
    Sun X; Wang Q; Wang Y; Du L; Xu C; Liu Q
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of danshensu on redox state and relevant nuclear transcription factors in non-small cell lung cancer A549 cells].
    Tao L; Wang S; Zhao Y; Chen W; Wang A; Lu Y
    Zhongguo Zhong Yao Za Zhi; 2012 May; 37(9):1265-8. PubMed ID: 22803373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation.
    Zhang G; Wang W; Yao C; Ren J; Zhang S; Han M
    Biomed Pharmacother; 2017 Jul; 91():147-154. PubMed ID: 28453992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells.
    Papaiahgari S; Zhang Q; Kleeberger SR; Cho HY; Reddy SP
    Antioxid Redox Signal; 2006; 8(1-2):43-52. PubMed ID: 16487036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with erlotinib and a transforming growth factor-β type I receptor inhibitor effectively suppresses the enhanced motility of erlotinib-resistant non-small-cell lung cancer cells.
    Serizawa M; Takahashi T; Yamamoto N; Koh Y
    J Thorac Oncol; 2013 Mar; 8(3):259-69. PubMed ID: 23334091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
    Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
    Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reoxygenation Reverses Hypoxia-related Radioresistance in Head and Neck Cancer Cell Lines.
    Tonissi F; Lattanzio L; Astesana V; Cavicchioli F; Ghiglia A; Monteverde M; Vivenza D; Gianello L; Russi E; Merlano M; Lo Nigro C
    Anticancer Res; 2016 May; 36(5):2211-5. PubMed ID: 27127125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.